Skip to main content
Subramaniam Sriram, MD, Neurology, Nashville, TN

SubramaniamSriramMD

Neurology Nashville, TN

Neuroimmunology/Multiple Sclerosis

Professor, Neurology, Vanderbilt University School of Medicine

Dr. Sriram is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Sriram's full profile

Already have an account?

  • Office

    3601 21st Ave S
    Nashville, TN 37232
    Phone+1 615-322-3000

Education & Training

  • Stanford Health Care-Sponsored Stanford University
    Stanford Health Care-Sponsored Stanford UniversityResidency, Pathology-Anatomic and Clinical, 1979 - 1981
  • Stanford Health Care-Sponsored Stanford University
    Stanford Health Care-Sponsored Stanford UniversityResidency, Neurology, 1976 - 1979
  • Wayne State University School of Medicine
    Wayne State University School of MedicineResidency, Internal Medicine, 1975 - 1976
  • Detroit Medical Center/Wayne State University
    Detroit Medical Center/Wayne State UniversityInternship, Internal Medicine, 1973 - 1974
  • Madras Medical College
    Madras Medical CollegeClass of 1973

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1976 - Present
  • MI State Medical License
    MI State Medical License Current
  • TN State Medical License
    TN State Medical License 1993 - 2025
  • VT State Medical License
    VT State Medical License 1984 - 1994
  • American Board of Internal Medicine Internal Medicine
  • American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

  • Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012

Publications & Presentations

PubMed

Press Mentions

  • Drug’s Effectiveness for Neurosarcoidosis Studied
    Drug’s Effectiveness for Neurosarcoidosis StudiedNovember 16th, 2017

Grant Support

  • Neuroimaging And Neuroprotection Of Primary OligodendrogliopathyNational Institute Of Neurological Disorders And Stroke2008–2009
  • Novel Oral Therapeutics For Multiple SclerosisNational Institute Of Neurological Disorders And Stroke2005–2006
  • Analysis Of Association Between C. Pneumoniae And MSNational Institute Of Neurological Disorders And Stroke2000–2002
  • Acute Exacerbations Of Multiple SclerosisNational Center For Research Resources1999–2002
  • High Dose Cytoxan In Patients With Chronic Progressive Multiple SclerosisNational Center For Research Resources1991–1994
  • Analysis Of In Vivo HPRT Mutant T Cells In MSNational Institute Of Neurological Disorders And Stroke1993
  • Analysis Of In Vivo HPRT Mutant T Cells In MSNational Institute Of Neurological Disorders And Stroke1991–1993
  • Immunology CoreNational Institute Of Allergy And Infectious Diseases1988–1990
  • Immune Response Of EMC Virus-Induced EncephalomyocarditisNational Institute Of Allergy And Infectious Diseases1988–1990
  • Action Of Anti I-A Antibodies In Suppression Of EAENational Institute Of Neurological Disorders And Stroke1985–1989
  • In Vivo Effects Of Anti I-A Antibody In EAENational Institute Of Neurological Disorders And Stroke1986–1988

Professional Memberships